SCHEMBL9194085

SCHEMBL9194085

CN(c1ncnc2c1ncn2Cc1ccccc1F)n1ccc2ccccc21

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 6/20 0.53
▸ PDE4B Q07343 6/20 0.53
▸ PDE4C Q08493 6/20 0.53
▸ PDE4D Q08499 6/20 0.53
▸ PDE5A O76074 3/20 0.53
▸ PDE1A P54750 3/20 0.53
▸ PDE1B Q01064 3/20 0.53
▸ PDE1C Q14123 3/20 0.53
▸ PDE3B Q13370 2/20 0.53
▸ PDE3A Q14432 2/20 0.53
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9196954 0.83 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL10442451 0.81 PDE4A (0.66) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL11017499 0.78 PDE4A (0.65) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL11016023 0.78 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL11014088 0.78 PDE4A (0.61) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL11016800 0.76 PDE4A (0.56) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL11018621 0.76 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL9194252 0.76 PDE4A (0.64) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL9191914 0.76 PI4KA (0.47) —
SCHEMBL9194840 0.71 PDE4A (0.67) PDE4APDE4BPDE4CPDE4DPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0668860-A1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES PHARMACIA & UPJOHN COMPANY (US) 1995-08-30 — — EP claimed
CN-1029968-C Process for preparation of N-heteroaryl-purin-6-amines and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1995-10-11 — — CN disclosed
EP-0402752-B1 N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1995-09-13 — — EP disclosed
US-5155098-A Analgesics, anticonvulsants HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-10-13 — — US disclosed
US-5017578-A N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1991-05-21 — — US disclosed
EP-0402752-A1 N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1990-12-19 — — EP disclosed
CN-1047866-A The preparation method of N-heteroaryl-purine-6-amine and medicinal HOECHST ROUSSEL PHARMA (US) 1990-12-19 — — CN disclosed
Send feedback